Education
About Us
Working with TipRanks
Follow Us
InterCure (INCR)
NASDAQ:INCR
INCR Stock Chart & Stats
$1.37
$0.04(2.22%)
At close: 4:00 PM EST
$1.37
$0.04(2.22%)
Day’s Range― - ―
52-Week Range$1.17 - $1.82
Previous CloseN/A
Volume20.32K
Average Volume (3M)105.31K
Market Cap
$76.55M
Enterprise Value$368.83M
Total Cash (Recent Filing)$78.65M
Total Debt (Recent Filing)$211.40M
Price to Earnings (P/E)―
Beta0.63
Next Earnings
Apr 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding54,512,608
10 Day Avg. Volume49,383
30 Day Avg. Volume105,312
Financial Highlights & Ratios
PEG Ratio-0.43
Price to Book (P/B)0.65
Price to Sales (P/S)1.09
P/FCF Ratio-3.64
Enterprise Value/Market Cap4.82
Enterprise Value/Revenue1.54
Enterprise Value/Gross Profit8.77
Enterprise Value/Ebitda-4.65
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Intercure News
INCR FAQ
What was InterCure’s price range in the past 12 months?
InterCure lowest stock price was $1.17 and its highest was $1.82 in the past 12 months.
What is InterCure’s market cap?
InterCure’s market cap is $76.55M.
When is InterCure’s upcoming earnings report date?
InterCure’s upcoming earnings report date is Apr 30, 2026 which is in 175 days.
How were InterCure’s earnings last quarter?
InterCure released its earnings results on Oct 08, 2025. The company reported -$0.011 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.011.
Is InterCure overvalued?
According to Wall Street analysts InterCure’s price is currently Overvalued.
Does InterCure pay dividends?
InterCure does not currently pay dividends.
What is InterCure’s EPS estimate?
InterCure’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InterCure have?
InterCure has 54,512,608 shares outstanding.
What happened to InterCure’s price movement after its last earnings report?
InterCure reported an EPS of -$0.011 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.617%.
Which hedge fund is a major shareholder of InterCure?
Currently, no hedge funds are holding shares in INCR
Intercure Stock Smart Score
Company Description
InterCure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 and is headquartered in Herzliya, Israel.
Technical Analysis
Ownership Overview
―
Insiders
0.04% Mutual Funds
0.02% Other Institutional Investors
99.11% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---